• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Vaxil Bio Ltd

+ Add to Watchlist

SEEEF:US

0.1500 USD 0.0150 11.11%

As of 20:10:06 ET on 12/09/2014.

Snapshot for Vaxil Bio Ltd (SEEEF)

Open: 0.1500 Day's Range: 0.1500 - 0.1500 Volume: 1,000
Previous Close: 0.1350 52wk Range: 0.1350 - 0.6700 1-Yr Rtn: -

Stock Chart for SEEEF

No chart data available.
  • SEEEF:US 0.1500
  • 1D
  • 1M
  • 1Y
0.1350
Interactive SEEEF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SEEEF

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 2.55
Shares Outstanding (M) 16.99
30 Day Average Volume 1,780
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SEEEF

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for SEEEF

Vaxil Bio Limited is a clinical stage company developing a new class of synthetic T-cell therapeutic and preventive vaccines with promiscuous MHC class I and II binding, based on its proprietary VaxHit technology.

Lior CarmonFounder/CEO/Head:ResearchJulian LevyPresident/CFO
Riva KovjazinDirector:ResearchOfira MoranClinical Trials Monitoring
More Company Profile & Key Executives for SEEEF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil